Amlodipine/Benazepril and Simvastatin Interaction

Understanding the Amlodipine/Benazepril and Simvastatin Interaction

FDA-approved prescribing information for these two drugs flags their combination as a major-severity interaction. Amlodipine/Benazepril belongs to the Calcium Channel Blocker / ACE Inhibitor Combination class and Simvastatin belongs to the HMG-CoA Reductase Inhibitor (Statin) class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: The amlodipine in this combination pill increases the amount of simvastatin that stays in your bloodstream. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Amlodipine/Benazepril has 7 total documented interactions on file in this dataset, and Simvastatin has 41. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Do not take more than 20 mg of simvastatin daily while you are taking this combination medicine. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Amlodipine/Benazepril or Simvastatin based on a web page, speak with your prescriber or pharmacist before making any change.